Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Linch

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Oncotargets and Therapy|August 13, 2013
Update on imatinib for gastrointestinal stromal tumors: duration of treatmentMark Linch, Jeroen Claus, Charlotte Benson
Current Opinion in Supportive and Palliative Care|March 29, 2014
Nonsurgical oncological management of cancer painNicholas Gough, Aisha B Miah, Mark Linch
European Urology|May 1, 2020
Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?Jasmin V Waterhouse, James H Hull, Mark Linch
Journal of Radiology Case Reports|January 15, 2014
Fistulation as a complication of intra-abdominal soft-tissue sarcomas; a case seriesBo Wang, Robert Thomas, Eleanor Moskovic, et al.
Nature Reviews. Urology|July 11, 2019
Molecular and histopathology directed therapy for advanced bladder cancerConstantine Alifrangis, Ursula McGovern, Alex Freeman, et al.
Sarcoma|April 12, 2013
Utility values for advanced soft tissue sarcoma health States from the general public in the United kingdomJulian F Guest, Erikas Sladkevicius, Nicholas Gough, et al.
Sarcoma|December 5, 2013
Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and swedenJulian F Guest, Monica Panca, Erikas Sladkevicius, et al.
Biochemical Pharmacology|November 16, 2013
Atypical protein kinase Cι as a human oncogene and therapeutic targetPeter J Parker, Verline Justilien, Philippe Riou, et al.
Nature Reviews. Clinical Oncology|March 20, 2014
Systemic treatment of soft-tissue sarcoma-gold standard and novel therapiesMark Linch, Aisha B Miah, Khin Thway, et al.
Current Opinion in Cell Biology|February 24, 2009
Protein kinase C intervention: the state of playJon Roffey, Carine Rosse, Mark Linch, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Oncotargets and Therapy|August 13, 2013
Update on imatinib for gastrointestinal stromal tumors: duration of treatmentMark Linch, Jeroen Claus, Charlotte Benson
Current Opinion in Supportive and Palliative Care|March 29, 2014
Nonsurgical oncological management of cancer painNicholas Gough, Aisha B Miah, Mark Linch
European Urology|May 1, 2020
Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?Jasmin V Waterhouse, James H Hull, Mark Linch
Journal of Radiology Case Reports|January 15, 2014
Fistulation as a complication of intra-abdominal soft-tissue sarcomas; a case seriesBo Wang, Robert Thomas, Eleanor Moskovic, et al.
Nature Reviews. Urology|July 11, 2019
Molecular and histopathology directed therapy for advanced bladder cancerConstantine Alifrangis, Ursula McGovern, Alex Freeman, et al.
Sarcoma|April 12, 2013
Utility values for advanced soft tissue sarcoma health States from the general public in the United kingdomJulian F Guest, Erikas Sladkevicius, Nicholas Gough, et al.
Sarcoma|December 5, 2013
Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and swedenJulian F Guest, Monica Panca, Erikas Sladkevicius, et al.
Biochemical Pharmacology|November 16, 2013
Atypical protein kinase Cι as a human oncogene and therapeutic targetPeter J Parker, Verline Justilien, Philippe Riou, et al.
Nature Reviews. Clinical Oncology|March 20, 2014
Systemic treatment of soft-tissue sarcoma-gold standard and novel therapiesMark Linch, Aisha B Miah, Khin Thway, et al.
Current Opinion in Cell Biology|February 24, 2009
Protein kinase C intervention: the state of playJon Roffey, Carine Rosse, Mark Linch, et al.
Pageof 5